The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The United States dry eye syndrome market is expected to exhibit a CAGR of X% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Dry eye syndrome, or keratoconjunctivitis sicca (KCS), is a medical disorder that occurs due to the lack of adequate moisture or lubrication on the surface of the eyes. It is caused due to multiple factors, such as extensive computer usage, menopause, allergies, deficiency of vitamin A, laser surgeries and autoimmune diseases. Dry eye syndrome is characterized by various symptoms, including aching, burning, redness, itchy eyes, pain, discomfort and photophobia. It can be treated by administering artificial tears, surgeries, medications and lacrimal plugs. Dry eye syndrome can be prevented by wearing wraparound sunglasses or other protective eyewear and avoiding excessive smoking.
The growth in the United States dry eye syndrome market can be attributed to the changing lifestyles of the masses and the increasing utilization of electronic gadgets, such as laptops, smartphones and television, leading to excessive and prolonged screen time. In addition, the rising utilization of contact lenses is also increasing the occurrence of dry eye syndrome. The material of the contact lens limits oxygen flow to the cornea and dries up the surface of the eyes. However, various product innovations, such as the development of a neurostimulation device that stimulates the lacrimal gland to temporarily increase natural tear production, are providing a thrust to the market growth. In line with this, the rising geriatric population, which is prone to chronic eye-related diseases, is also contributing to the growth of the market. Dry eye syndrome is associated with various medical conditions, such as rheumatoid arthritis, lupus, scleroderma and diabetes, which can trigger the syndrome in elderly patients. Other factors, including the widespread adoption of corticosteroids drugs for effective treatment, along with significant improvements in the healthcare infrastructure and diagnostic technologies, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the United States dry eye syndrome market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
Breakup by Drug Type:
Breakup by Product:
Breakup by Distribution Channel:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2021|
|Segment Coverage||Disease Type, Drug Type, Product, Distribution Channel, Region|
|Region Covered||Northeast, Midwest, South, West|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at